TY  - JOUR

T1  - Advances in the management of HER2-positive early breast cancer

JO  - Critical Reviews in Oncology/Hematology

PY  - 2017/01/01

AU  - Baselga J

AU  - Coleman RE

AU  - Cortés J

AU  - Janni W

ED  - 

DO  - DOI: 10.1016/j.critrevonc.2017.10.001

PB  - Elsevier BV

VL  - 119

SP  - 113

EP  - 122

Y2  - 2025/10/10

ER  -